Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey

Hellenic Journal of Cardiology - Tập 57 - Trang 33-38 - 2016
John Fanourgiakis1,2,3, Emmanuel Simantirakis1, Nikolaos Maniadakis4, Emmanuel Kanoupakis1, Stavros Chrysostomakis1, Georgia Kourlaba5,6, Gregory Chlouverakis7, Panos Vardas1
1Department of Cardiology, Heraklion University Hospital, Crete
2Faculty of Social Sciences, Hellenic Open University, Patra
3Department of Business Administration, Technological Educational Institute, Agios Nikolaos, Crete
4National School of Public Health, Athens
5The Stavros Niarchos Foundation-Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens
6National and Kapodistrian University of Athens, School of Medicine, Athens
7Department of Biostatistics, Faculty of Medicine, University of Crete, Crete, Greece

Tài liệu tham khảo

Lamas, 2004, Evidence base for pacemaker mode selection: from physiology to randomized trials, Circulation, 109, 443, 10.1161/01.CIR.0000115642.05037.0E Parsonnet, 1966, Clinical use of an implantable standby pacemaker, JAMA, 196, 784, 10.1001/jama.1966.03100220076025 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 Connolly, 2000, Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 Brignole, 2013, Eur Heart J, 34, 2281, 10.1093/eurheartj/eht150 Dickstein, 2010, Eur Heart J, 31, 2677, 10.1093/eurheartj/ehq027 Dickstein, 2008, Eur Heart J, 29, 2388, 10.1093/eurheartj/ehn309 Vardas, 2007, Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association, Eur Heart J, 28, 2256, 10.1093/eurheartj/ehm305 Stabile, 2015, Inducibility of ventricular arrhythmia and tachyarrhythmia recurrences in patients with implantable defibrillator, Hellenic J Cardiol, 56, 230 Poole, 2010, Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry, Circulation, 122, 1553, 10.1161/CIRCULATIONAHA.110.976076 Sideris, 2015, Transvenous extraction of cardiac rhythm device leads: a report of the experience from a single referral centre in Greece, Hellenic J Cardiol, 56, 55 van Eck, 2007, Incidence and predictors of in-hospital events after first implantation of pacemakers, Europace, 9, 884, 10.1093/europace/eum113 Udo, 2012, Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study, Heart Rhythm, 9, 728, 10.1016/j.hrthm.2011.12.014 Ellenbogen, 2003, Complications arising after implantation of DDD pacemakers: the MOST experience, Am J Cardiol, 92, 740, 10.1016/S0002-9149(03)00844-0 Møller, 2002, Quality assessment of pacemaker implantations in Denmark, Europace, 4, 107, 10.1053/eupc.2002.0234 Tobin, 2000, Acute complication of permanent pacemaker implantation: their financial implication and relation to volume and operator experience, Am J Cardiol, 85, 774, 10.1016/S0002-9149(99)00861-9 Harcombe, 1998, Late complications following permanent pacemaker implantation or elective unit replacement, Heart, 80, 240, 10.1136/hrt.80.3.240 Pakarinen, 2010, Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey, Europace, 12, 103, 10.1093/europace/eup361 Parsonnet, 1989, Pacemaker-implantation complication rates: an analysis of some contributing factors, J Am Coll Cardiol, 13, 917, 10.1016/0735-1097(89)90236-2 Mueller, 1990, Complications after single versus dual chamber pacemaker implantation, Pacing Clin Electrophysiol, 13, 711, 10.1111/j.1540-8159.1990.tb02095.x Klug, 2007, Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study, Circulation, 116, 1349, 10.1161/CIRCULATIONAHA.106.678664 Gould, 2006, Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories, JAMA, 295, 1907, 10.1001/jama.295.16.1907 Reynolds, 2006, The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators, J Am Coll Cardiol, 47, 2493, 10.1016/j.jacc.2006.02.049 van Rees, 2011, Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials, J Am Coll Cardiol, 58, 995, 10.1016/j.jacc.2011.06.007 Zhan, 2008, Cardiac device implantation in the United States from 1997 through 2004: a Population-based analysis, J Gen Intern Med, 23, 13, 10.1007/s11606-007-0392-0 Bongiorni, 2012, How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey, Europace, 14, 1666, 10.1093/europace/eus350